Authorities in many countries are scrambling for solutions to mounting shortages of medicine. Will any of them work?
Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...
FY25 saw AdAlta (ASX:1AD) focus on increasing its corporate muscle, with two new board members and additional advisors engaged.
Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.
The illicit trade of fake medicines is a “growing threat” in Europe, EU’s law enforcement agency warned today. There is a rise in the trade of either sub-standard, falsely labelled or falsified ...
GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the Marketing Authorisation Application, MAA, for the use of depemokimab in two indications. The submitted indicati ...
Donald Trump continues to make waves in biopharma; Sage rejects Biogen’s unsolicited takeover offer; the obesity space sees ...
Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...
Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...
Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and ...
GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...
The government agency says X no longer suits its communication needs.